This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nilsson, J. Search for Related Content PubMed PubMed Citation Articles by Nilsson, J. Related Collections Related Article

(Circulation Research. 2005;96:395.)
© 2005 American Heart Association, Inc.

Editorials

Regulating Protective Immunity in Atherosclerosis

Jan Nilsson

From the Department of Clinical Sciences, Malmö University Hospital, Lund University, Sweden.

Correspondence to Jan Nilsson, Department of Clinical Sciences, Entrance 33, 1st floor, Malmö University Hospital, S-205 02 Malmö, Sweden. E-mail jan.nilsson@medforsk.mas.lu.se

Key Words: T cells • adaptive immunity • lipoproteins • oxidation

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Atherosclerosis is a disease characterized by chronic inflammation. Looking back it is almost embarrassing how long it took for us to realize that the presence of these innate immune responses also was associated with activation of adaptive immunity. The first hints of an involvement of adaptive immunity in atherosclerosis came from studies performed by Göran Hansson and his coworkers about 20 years ago demonstrating the presence of activated T cells and expression of class II molecules in atherosclerotic plaques.¹ This finding provoked an intense interest in the role of immunity in atherosclerosis, and it is now generally recognized that adaptive immune responses have a key role in determining the balance between disease progression and regression.² It also focused attention on the immune system as a target for prevention and treatment of cardiovascular disease. Mice with defective adaptive immunity, such as SCID and Rag-1, develop less atherosclerosis indicating that adaptive immune responses are primarily proatherogenic. Oxidized LDL has been identified as one of the most important autoantigens in atherosclerosis.³ A large fraction of the T cells present in atherosclerotic plaques are specific for oxidized LDL,⁴ and oxidized LDL IgG is prevalent in the circulation of both humans and atherosclerosis-prone animals. However, studies evaluating the role of immune responses against oxidized LDL by immunizing animals with in vitro oxidized LDL unexpectedly revealed a protective effect.^5,6 Although it still remains to be established whether naturally occurring autoimmune responses against oxidized LDL also have atheroprotective effects, these observations suggest the fascinating possibility of developing . . . [Full Text of this Article]

Related Article:

Lesion Development and Response to Immunization Reveal a Complex Role for CD4 in Atherosclerosis

Xinghua Zhou, Anna-Karin L. Robertson, Mats Rudling, Paolo Parini, and Göran K. Hansson
Circ. Res. 2005 96: 427-434. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				J. Feng, Z. Zhang, W. Kong, B. Liu, Q. Xu, and X. Wang Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice Cardiovasc Res, October 1, 2009; 84(1): 155 - 163. [Abstract] [Full Text] [PDF]